# Increlex

NDC: 71863-216
Generic name: Mecasermin
Labeler / Manufacturer: Eton Pharmaceuticals, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Biologic License Application
Dosage form: INJECTION
Routes: SUBCUTANEOUS
Marketing started: 20250416

FDA application: BLA021839

## Active ingredients

- MECASERMIN: 40 mg/4mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"71863-216"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=71863-216
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=d5b2b0e1-c523-468d-9a0b-4ae4e4a8dbce